Skip to Content

Information for Journalists

To request an interview with a DCEG investigator, contact the NCI Office of Media Relations:

E-mail:
ncipressofficers@
mail.nih.gov

Phone: 301-496-6641
 

Negative HPV test result is better predictor of low cervical cancer risk than negative Pap test

Posted on July 18, 2014

Based on a study that included more than 1 million women, DCEG investigators and colleagues have determined that a negative test for human papillomavirus (HPV) infection compared to a negative Pap test provides greater safety, or assurance, against future risk of cervical cancer. That is, women who test negative on the HPV test have an extremely low risk of developing cervical cancer. The findings appeared online July 18, 2014, in the Journal of the National Cancer Institute. Read the full NCI press release on this study

Reference: Gage JC, Schiffman M, Katki HA, et al. Reassurance against future risk of precancer and cancer conferred by a negative human papillomavirus test. J Natl Cancer Inst 2014; 106(8).doi: 10.1093/jnci/dju153.